Top

Published in:

01-05-2009 | ORIGINAL CONTRIBUTION

The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure

Authors: Rob F. Wiegerinck, PhD, Jacques M. T. de Bakker, PhD, Tobias Opthof, PhD, Nicolaas de Jonge, MD, PhD, Hans Kirkels, MD, PhD, Francien J. G. Wilms-Schopman, RA, Ruben Coronel, MD, PhD

Published in: Basic Research in Cardiology | Issue 3/2009

Abstract

Aim

To investigate ventricular conduction and refractoriness before and after application of rotigaptide, an enhancer of gap junctional conductance, to explanted hearts of patients with heart failure (HF).

Methods and results

In six explanted perfused hearts of patients with end-stage HF, activation/repolarization mapping was performed and refractory periods (RPs) and activation recovery intervals (ARIs) were measured before and after application of 50 nM rotigaptide. Rotigaptide caused a decrease of RP from 476 ± 36 to 453 ± 31 ms (P < 0.05), but did not change ARI-dispersion. During premature activation along the fibers rotigaptide decreased the minimal activation time (AT_min) and maximal activation time (AT_max) significantly from 35 ± 12 to 24 ± 9 and from 97 ± 38 to 43 ± 7 ms, respectively. Rotigaptide did not change AT_min and AT_max during activation perpendicular to the fiber direction. After application of rotigaptide conduction curves normalized in five/six recordings when activation was parallel, but destabilized in three/six hearts when activation was perpendicular to fiber direction. The destabilization was associated with local conduction delays rather than with facilitation of conduction.

Conclusion

Rotigaptide applied to hearts of patients with end-stage HF shortened RPs normalized conduction curves and increased conduction parallel to fiber direction. However, in 50% of the hearts local slowing of conduction with destabilization of conduction (curves) occurs at sites close to the stimulation site, when activation is perpendicular to fiber direction.

Ai X, Pogwizd SM (2005) Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ Res 96:54–63PubMedCrossRef

Akar FG, Spragg DD, Tunin RS, Kass DA, Tomaselli GF (2004) Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 95:717–725PubMedCrossRef

Akar FG, Nass RD, Hahn S, Cingolani E, Shah M, Hesketh GG, DiSilvestre D, Tunin RS, Kass DA, Tomaselli GF (2007) Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am J Physiol Heart Circ Physiol 293:H1223–H1230PubMedCrossRef

Conrath CE, Wilders R, Coronel R, De Bakker JMT, Taggart P, de Groot JR, Opthof T (2004) Intercellular coupling through gap junctions masks M cells in the human heart. Cardiovasc Res 62:407–414PubMedCrossRef

Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR, Bhuiyan Z, Bezzina C, Veldkamp MW, Linnenbank AC, van der Wal AC, Tan HL, Brugada P, Wilde AAM, de Bakker JM (2005) Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome. A combined electrophysiological, genetic, histopathological and computational study. Circulation 112:2769–2777PubMedCrossRef

Coronel R, de Bakker JM, Wilms-Schopman FJ, Opthof T, Linnenbank AC, Belterman CN, Janse MJ (2006) Monophasic action potentials and activation recovery intervals as measures of ventricular action potential duration: experimental evidence to resolve some controversies. Heart Rhythm 3:1043–1050PubMedCrossRef

de Bakker JM, van Capelle FJ, Janse MJ, van Hemel NM, Hauer RN, Defauw JJ, Vermeulen FE, Bakker de Wekker PF (1991) Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a “focal” activation pattern. J Am Coll Cardiol 18:1005–1014PubMedCrossRef

Delmar M, Michaels DC, Johnson T, Jalife J (1987) Effects of increasing intercellular resistance on transverse and longitudinal propagation in sheep epicardial muscle. Circ Res 60:780–785PubMed

Dhein S, Hammerath B (2001) Aspects of the intercellular communication in aged hearts: effects of the gap junction uncoupler palmitoleic acid. Naunyn Schmiedebergs Arch Pharmacol 364:397–408PubMedCrossRef

10.

Dhein S, Kruseman K, Schaefer T (1999) Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br J Pharmacol 128:1375–1384PubMedCrossRef

11.

Dhein S, Larsen BD, Petersen JS, Mohr FW (2003) Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern. Cell Commun Adhes 10:371–378PubMedCrossRef

12.

Eloff BC, Gilat E, Wan X, Rosenbaum DS (2003) Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation 108:3157–3163PubMedCrossRef

13.

Fast VG, Kléber AG (1995) Block of impulse propagation at an abrupt tissue expansion: evaluation of the critical strand diameter in 2- and 3-dimensional computer models. Cardiovasc Res 30:449–459PubMed

14.

Fast VG, Kléber AG (1995) Cardiac tissue geometry as a determinant of unidirectional conduction block: assessment of microscopic excitation spread by optical mapping in patterned cell cultures and in a computer model. Cardiovasc Res 29:697–707PubMed

15.

Fischer P, Hilfiker-Kleiner D (2007) Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol 102:393–411PubMedCrossRef

16.

Guerra JM, Everett TH IV, Lee KW, Wilson E, Olgin JE (2006) Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 114:110–118PubMedCrossRef

17.

Haugan K, Olsen KB, Hartvig L, Petersen JS, Holstein-Rathlou NH, Hennan JK, Nielsen MS (2005) The antiarrhythmic peptide analog ZP123 prevents atrial conduction slowing during metabolic stress. J Cardiovasc Electrophysiol 16:537–545PubMedCrossRef

18.

Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, de Bakker JM (2001) Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 104:3069–3075PubMedCrossRef

19.

Kjølbye AL, Knudsen CB, Jepsen T, Larsen BD, Petersen JS (2003) Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-d-Tyr-d-Pro-d-Hyp-Gly-d-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J Pharmacol Exp Ther 306:1191–1199PubMedCrossRef

20.

Kleber AG, Janse MJ, Wilms-Schopman FJG, Wilde AAM, Coronel R (1986) Changes in conduction velocity during acute ischemia in ventricular myocardial isolated porcine heart. Circulation 73:189–198PubMed

21.

Kwak BR, Jongsma HJ (1996) Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol Cell Biochem 157:93–99PubMedCrossRef

22.

Lammers WJEP, Schalij MJ, Kirchhof CJHJ, Allessie MA (1990) Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol 259:H1254–H1263PubMed

23.

Lesh MD, Pring M, Spear JF (1989) Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. A computer modeling study. Circ Res 65:1426–1440PubMed

24.

Mines GR (1914) On circulating excitation in heart muscles and their possible relation to tachycardia and fibrillation. Trans R Soc Can IV:43–52

25.

Muller A, Schaefer T, Linke W, Tudyka T, Gottwald M, Klaus W, Dhein S (1997) Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch Pharmacol 356:76–82PubMedCrossRef

26.

Peters NS, Coromilas J, Severs NJ, Wit AL (1997) Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95:988–996PubMed

27.

Potse M, Linnenbank AC, Grimbergen CA (2002) Software design for analysis of multichannel intracardial and body surface electrocardiograms. Comput Methods Programs Biomed 69:225–236PubMedCrossRef

28.

Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Martinez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP, Diez J (2000) Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101:1729–1735PubMed

29.

Rohr S, Kucera JP, Fast VG, Kléber AG (1997) Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science 275:841–844PubMedCrossRef

30.

Sáez JC, Nairn AC, Czernik AJ, Fishman GI, Spray DC, Hertzberg EL (1997) Phosphorylation of connexin 43 and the regulation of neonatal rat cardiac myocyte gap junctions. J Mol Cell Cardiol 29:2131–2145PubMedCrossRef

31.

Schulz R, Boengler K, Totzeck A, Luo Y, Garcia-Dorado D, Heusch G (2007) Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev 12:261–266PubMedCrossRef

32.

Shaw RM, Rudy Y (1997) Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res 81:727–741PubMed

33.

Spach MS, Heidlage JF, Dolber PC, Barr RC (2008) Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study. Heart Rhythm 4:175–185CrossRef

34.

Wang Y, Rudy Y (2000) Action potential propagation in inhomogeneous cardiac tissue: safety factor considerations and ionic mechanism. Am J Physiol Heart Circ Physiol 278:H1019–H1029PubMed

35.

Weng S, Lauven M, Schaefer T, Polontchouk L, Grover R, Dhein S (2002) Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 16:1114–1116PubMed

36.

Wiegerinck RF, van Veen AA, Belterman CN, Schumacher CA, Noorman M, de Bakker JM, Coronel R (2008) Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin 43 in a rabbit model of heart failure. Heart Rhythm 5:1178–1185PubMedCrossRef

37.

Wilders R, Wagner MB, Golod DA, Kumar R, Wang Y-G, Goolsby WN, Joyner RW, Jongsma HJ (2000) Effects of anisotropy on the development of cardiac arrhythmias associated with focal activity. Pflügers Arch Eur J Physiol 441:301–312CrossRef

38.

Xing D, Kjølbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH, Martins JB (2003) ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol 14:510–520PubMedCrossRef

Title: The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure
Authors: Rob F. Wiegerinck, PhD
Jacques M. T. de Bakker, PhD
Tobias Opthof, PhD
Nicolaas de Jonge, MD, PhD
Hans Kirkels, MD, PhD
Francien J. G. Wilms-Schopman, RA
Ruben Coronel, MD, PhD
Publication date: 01-05-2009
Publisher: Steinkopff-Verlag
Published in: Basic Research in Cardiology / Issue 3/2009
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-008-0771-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure

Abstract

Aim

Methods and results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aim

Methods and results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2009

Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice

Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin

Impact of myocardial inflammation on cytosolic and mitochondrial creatine kinase activity and expression

Vascular control in humans: focus on the coronary microcirculation

Beta2-integrin activation on T cell subsets is an independent prognostic factor in unstable angina pectoris

Modulation of L-type Ca2+ channel current density and inactivation by β-adrenergic stimulation during murine cardiac embryogenesis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page